Menlo Ventures

Bio Roundup: Grail Acquisition, Libra's Launch, Tau Trial Results & More

Bio Roundup: Grail Acquisition, Libra's Launch, Tau Trial Results & More

2 hours ago   |   Xconomy

In biotech, you can go home again. Four years ago, Illumina spun out cancer diagnostics startup Grail. This week, the gene sequencing giant announced it is acquiring Grail in...
Read more ...

Monte Rosa Raises $96M for “Glue-Based” Protein Degrading Drugs

Monte Rosa Raises $96M for “Glue-Based” Protein Degrading Drugs

1 day ago   |   Xconomy

Many drugs work by binding to a protein and blocking it. Technology for eliminating disease-causing proteins altogether remains experimental, but this approach has gained...
Read more ...

Libra Strikes a Balance With Approach to ALS and Other Neuro Disorders

Libra Strikes a Balance With Approach to ALS and Other Neuro Disorders

1 day ago   |   Xconomy

Amyotrophic lateral sclerosis has no cure and few available treatments but the past decade has revealed new knowledge about the pathology of the disease. Libra Therapeutics is...
Read more ...

Research Associate - Singular Genomics - San Diego, CA

3 days ago   |   San Diego Biotechnology   |   2 articles

Singular Genomics is inventing at the forefront of genomics, one of the world's fastest-growing industries. We are a venture-backed biotech company in La Jolla,... From...
Read more ...

PetDx: Research Scientist Contractor

3 days ago   |   San Diego Biotechnology

PetDx: PetDx is venture-backed San Diego based genomics/molecular diagnostics startup focused on the development of breakthrough... San Diego, CA ...
Read more ...

Illumina to Acquire Cancer Diagnostics Developer Grail in $8B Deal

Illumina to Acquire Cancer Diagnostics Developer Grail in $8B Deal

4 days ago   |   Xconomy

Grail is set to be acquired for $8 billion by Illumina, the gene sequencing giant that formed the cancer diagnostics developer and spun it out as a separate company four years...
Read more ...

Illumina to Acquire GRAIL to Launch New Era of Cancer Detection

4 days ago   |   San Diego Biotechnology

SAN DIEGO & MENLO PARK, Calif.--- $ILMN ILMN-Illumina, Inc. and GRAIL, a healthcare company whose mission is focused on multi-cancer early detection, today announced they have...
Read more ...

Bio Roundup: SeaGen Scores, Dyne's Debut, Microbiome Moves & More

Bio Roundup: SeaGen Scores, Dyne's Debut, Microbiome Moves & More

7 days ago   |   Xconomy

Gilead Sciences CEO Daniel O'Day has spoken openly about acquisitions as a way to build up the company's drug pipeline. This week, it made its biggest buy yet. The $21 billion...
Read more ...

Finch Therapeutics Fetches $90M to Advance Microbiome Drug Pipeline

Finch Therapeutics Fetches $90M to Advance Microbiome Drug Pipeline

8 days ago   |   Xconomy

When Seres Therapeutics reported positive late-stage data for its experimental microbiome treatment last month, scientists at Finch Therapeutics cheered the results from the...
Read more ...

Neogene Therapeutics Grabs $110M to Tackle Solid Tumors With Cell Therapy

Neogene Therapeutics Grabs $110M to Tackle Solid Tumors With Cell Therapy

9 days ago   |   Xconomy

Cell therapy offers another option for addressing the most difficult blood cancer cases, but such treatments, which are engineered from a patient's own immune cells, don't yet...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Bio Roundup: Grail Acquisition, Libra's Launch, Tau Trial Results & More

Bio Roundup: Grail Acquisition, Libra's Launch, Tau Trial Results & More

In biotech, you can go home again. Four years ago, Illumina spun out cancer diagnostics startup Grail. This week, the gene sequencing giant announced it is acquiring Grail in... Read more ...

Combined Therapeutics Wins $250,000 MilliporeSigma Advance Biotech Grant

Combined Therapeutics Wins $250,000 MilliporeSigma Advance Biotech Grant

MilliporeSigma has awarded MIT spin-out Combined Therapeutics a check for $250,000 as the winner of its 2020 Advance Biotech Grant. Combined Therapeutics is an early stage... Read more ...

Machine Learning Takes on Synthetic Biology: Algorithms Can Bioengineer...

Machine Learning Takes on Synthetic Biology: Algorithms Can Bioengineer Cells for You

Tijana Radivojevic and Hector Garcia Martin working on mechanical and statistical modeling, data visualizations, and metabolic maps at the Agile BioFoundry last year. If... Read more ...

And the 2020 National Xconomy Awards Winners Are

And the 2020 National Xconomy Awards Winners Are

Congratulations to all the finalists and winners! This year we received over 600 nominations across 10 award categories. Each nomination was carefully reviewed and ranked by... Read more ...

Talking Alone: Researchers Use Artificial Intelligence Tools to Predict...

Talking Alone: Researchers Use Artificial Intelligence Tools to Predict Loneliness

A team led by researchers at University of California San Diego School of Medicine has used artificial intelligence technologies to analyze natural language patterns to discern... Read more ...

Monte Rosa Raises $96M for “Glue-Based” Protein Degrading Drugs

Monte Rosa Raises $96M for “Glue-Based” Protein Degrading Drugs

Many drugs work by binding to a protein and blocking it. Technology for eliminating disease-causing proteins altogether remains experimental, but this approach has gained... Read more ...

Libra Strikes a Balance With Approach to ALS and Other Neuro Disorders

Libra Strikes a Balance With Approach to ALS and Other Neuro Disorders

Amyotrophic lateral sclerosis has no cure and few available treatments but the past decade has revealed new knowledge about the pathology of the disease. Libra Therapeutics is... Read more ...

New method allows precise gene control by light

A novel optical switch makes it possible to precisely control the lifespan of genetic copies. These are used by the cell as building instructions for the production of... Read more ...

Tuning Monoclonal Antibody Galactosylation using Raman...

Abstract A key aspect of large‐scale production of biotherapeutics is a well‐designed and consistently‐executed upstream cell culture process. Process Analytical Technology... Read more ...

Modeling tangential flow filtration using reverse asymmetric membranes for...

Abstract Tangential flow filtration has many advantages for bioreactor harvesting as the permeate could be introduced directly to the subsequent capture step. However, membrane... Read more ...